Vascular Supply Identification, Lesion Extension and Search for Tumor Similarity at a Distance by VTM in Breast Cancer - Trial NCT06045572

Timeline & Enrollment

Primary Outcome

Concordance of the diagnosis of abnormality during the VTM exam in relation to the standard exam (mammography);,Frequency of non-visible vascular identification:,Frequency of identifying non-visible textures,Frequency of thermal discrepancy in nearby pixels in areas suspected of non-visible abnormalities:,Frequency of sample changes detected by VTM

Summary

When we talk about early identification, we are talking about an ALREADY EXISTING INJURY,
 triggering a change in the patient's quality of life and a projection of future costs for the
 health system.
 
 INNOVATIVE ASPECT: While screening mammography identifies an existing lesion, VTM could: Make
 an early diagnosis before the formation of a visible or palpable tumor mass; Check the
 metabolic activity in suspicious lesions identified by other diagnostic methods; Demarcate
 tumor range and tumor similarity from a distance in breast cancer.
 
 Regarding the Risk x Benefit:There are no medications incorporated, associated or
 administered by the equipment; There is no ionizing radiation incorporated or delivered by
 the equipment; There are no contraindications for the use of the equipment by the patient
 (Non-ionizing infrared radiation, without contrast or contact); Audience destined to operate
 the equipment: Physician / Radiologist with training Therefore, the research in question is
 of great relevance for such a debilitating health problem for the patient and for the health
 system.

ICD-10 Classifications